Jeffrey Chodakewitz, EVP GMDA, CMO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 10,080 shares at $143.54 ($1.5M) on 2017-11-02, disclosed to the SEC on 2017-11-06.
Open-market sale of $1.5M VRTX by EVP GMDA, CMO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $143.54 | 400 | $57K | 3.9% |
| 2 | $144.89 | 1,096 | $159K | 10.9% |
| 3 | $144.89 | 1,096 | $159K | 10.9% |
| 4 | $145.89 | 300 | $44K | 3.0% |
| 5 | $144.69 | 3,594 | $520K | 35.6% |
| 6 | $144.69 | 3,594 |
| $520K |
| 35.6% |
| Total | $144.72 avg | 10,080 | $1.5M | 100% |
| Filing → |
| VRTX | SELL | 2018-02-05 | $782K | — | Filing → |
| VRTX | SELL | 2018-01-17 | $351K | — | Filing → |
| VRTX | SELL | 2018-01-03 | $756K | — | Filing → |